Diversify Advisory Services’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$915K Buy
3,946
+1,390
+54% +$273K 0.02% 664
2026
Q1
$484K Sell
2,556
-769
-23% -$149K 0.07% 119
2025
Q4
$630K Buy
3,325
+213
+7% +$38.8K 0.02% 532
2025
Q3
$556K Buy
3,112
+11
+0.4% +$1.95K 0.02% 532
2025
Q2
$554K Buy
3,101
+1,714
+124% +$298K 0.02% 503
2025
Q1
$248K Buy
+1,387
New +$228K 0.02% 555

Other funds holding DGX

Diversify Advisory Services's DGX Position: Q2 2026 in Review

Diversify Advisory Services increased its Quest Diagnostics (DGX) stake by 54% in Q2 2026, buying an estimated $273K and bringing the position to 3,946 shares worth $915K. The position accounts for 0.02% of the portfolio, ranked #664.

Diversify Advisory Services first reported a position in DGX in Q1 2025 and has held it in 6 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Diversify Advisory Services held 3,946 shares of Quest Diagnostics worth $915K as of Q2 2026.
  • Diversify Advisory Services bought 1,390 Quest Diagnostics shares in Q2 2026, an estimated $273K.
  • Quest Diagnostics made up 0.02% of Diversify Advisory Services's portfolio in Q2 2026, its #664 holding.
  • Diversify Advisory Services first reported a position in Quest Diagnostics in Q1 2025 and has held it in 6 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Diversify Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.